M&A Deal Summary |
|
---|---|
Date | 2024-04-30 |
Target | Deciphera |
Sector | Life Science |
Buyer(s) | Ono Pharmaceutical |
Deal Type | Merger |
Deal Value | 2.4B USD |
Advisor(s) | J.P. Morgan Securities (Financial) Goodwin Procter (Legal) |
SEARCH BY
Try For Free 7-Day Free Trial
Ono Pharmaceutical is a pharmaceutical company with major plants in Higashinari-ku, Osaka, Fujinomiya, and Shizuoka., and a central research institute at Minase, Shimamoto-cho, Mishima District, Osaka. Ono Pharmaceutical is based in Osaka, Japan.
DEAL STATS | # |
---|---|
Overall | 1 of 1 |
Sector (Life Science) | 1 of 1 |
Type (Merger) | 1 of 1 |
State (Massachusetts) | 1 of 1 |
Country (United States) | 1 of 1 |
Year (2024) | 1 of 1 |
Size (of disclosed) | 1 of 1 |